STOCKS | Blue Owl-Backed Latigo Biotherapeutics Files for IPO
2026-07-17 18:03:32
Latigo Biotherapeutics Inc., backed by Blue Owl, filed for an initial public offering, according to Bloomberg. The biotech company joins a growing list of firms considering going public as soon as this quarter.
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
Previous article：
世界杯 | 西班牙训练受山火烟霾影响Next article：
Spreadefi二季度流动性池资金超2500万美元
